Recent PhD graduate Vanessa Dippon has investigated a new “hidden control dial” that has the potential to improve the ability of cancer therapies to target harmful proteins while sparing healthy cells.
Targeted protein degradation therapeutics offer new hope for those suffering from cancer. Researchers have focused on cereblon, a protein that helps cells maintain a stable internal environment,…
